WallStreetZenWallStreetZen

NASDAQ: CLGN
Collplant Biotechnologies Ltd Earnings & Revenue

CLGN past revenue growth

How has CLGN's revenue growth performed historically?
Company
1,495.2%
Industry
89.08%
Market
19.74%
CLGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CLGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CLGN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CLGN earnings and revenue history

Current Revenue
$10.6M
Current Earnings
-$7.5M
Current Profit Margin
-70.6%

CLGN Return on Equity

Current Company
-24.7%
Current Industry
16.8%
Current Market
28.2%
CLGN's Return on Equity (-24.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CLGN announces earnings.

CLGN Return on Assets

Current Company
-20.9%
Current Industry
3.2%
CLGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CLGN Return on Capital Employed

Current Company
-29.75%
Current Industry
-42.4%
CLGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CLGN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CLGN$10.62M-$6.89M-$7.50M+14.57%N/A
RLYB$0.00-$76.13M-$76.28MN/AN/A
CELU$14.79M-$169.66M-$181.41M-81.46%N/A
EYEN$8.78k-$29.01M-$32.44M-99.93%N/A
TSBX$0.00-$72.49M-$74.92M-100.00%N/A

CLGN earnings dates

Next earnings date
Aug 22, 2024

Collplant Biotechnologies Earnings & Revenue FAQ

What were CLGN's earnings last quarter?

On Invalid Date, Collplant Biotechnologies (NASDAQ: CLGN) reported Q1 2024 earnings per share (EPS) of -$0.37, up 12.12% year over year. Total Collplant Biotechnologies earnings for the quarter were -$4.20 million. In the same quarter last year, Collplant Biotechnologies's earnings per share (EPS) was -$0.33.

If you're new to stock investing, here's how to buy Collplant Biotechnologies stock.

What was CLGN's earnings growth in the past year?

As of Q3 2024, Collplant Biotechnologies's earnings has grown year over year. Collplant Biotechnologies's earnings in the past year totalled -$7.50 million.

What is CLGN's earnings date?

Collplant Biotechnologies's earnings date is Invalid Date. Add CLGN to your watchlist to be reminded of CLGN's next earnings announcement.

What was CLGN's revenue last quarter?

On Invalid Date, Collplant Biotechnologies (NASDAQ: CLGN) reported Q1 2024 revenue of $98.00 thousand up 77.37% year over year. In the same quarter last year, Collplant Biotechnologies's revenue was $433.00 thousand.

What was CLGN's revenue growth in the past year?

As of Q3 2024, Collplant Biotechnologies's revenue has grown 1,495.2% year over year. This is 1,406.12 percentage points higher than the US Biotechnology industry revenue growth rate of 89.08%. Collplant Biotechnologies's revenue in the past year totalled $10.62 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.